Companies Dominating the Rapid Influenza Diagnostic Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hologic, Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Abbott Laboratories
- BD
- F. Hoffmann-La Roche Ltd
- NeuroLogica Corp.
- GENERAL ELECTRIC
- Quest Diagnostics Incorporated
- DiaSorin SpA
Browse Key Market Insights with Data Illustration:
In the News
- For its quick influenza diagnostic testing device, ID NOW INFLUENZA A & B 2, Abbott got U.S. FDA approval in October 2018. The influenza A and B viruses may be quickly identified and differentiated molecularly with this assay. This product approval helped the business increase its market presence and diversify its offering of influenza diagnostic tests.
- The acquisition of Luminex Corporation, a business involved in the development of diagnostic tools for infectious diseases, was announced by DiaSorin SpA in April 2021. The goal of this acquisition was to increase the diagnostic goods available in the United States, including those for the diagnosis of influenza. This tactical choice helped the business grow its clientele and strengthen its position in the market.
